COVID-19: A Local Report on Patients in the Covid Ward in Bytom, Poland
Letters in Applied NanoBioScience · 30.06.2026 · 15 (2)
DOI: 10.33263/lianbs152.076 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Applied NanoBioScience, online erschienen am 30.06.2026. Verfasst von David Aebisher und 8 weiteren Autor:innen. Die Arbeit nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The objective of this study was to characterize the clinical profile, laboratory findings, treatment strategies, and outcomes of patients hospitalized with COVID-19 at the Department and Clinic of Internal Medicine, Angiology and Physical Medicine in Bytom, Poland, during the period from December 2021 to March 2022. A total of 120 adult patients with confirmed SARS-CoV-2 infection were retrospectively analyzed. Data included demographic information, vaccination status, comorbidities, laboratory biomarkers (CRP, IL-6, D-dimer), treatment modalities (including antibiotics, corticosteroids, anticoagulants, antivirals, and immunomodulators), and in-hospital mortality. Statistical analysis was performed using ANOVA, with significance set at p < 0.05. Most patients were over 75 years old and had multiple comorbidities such as hypertension (57.5%), diabetes (40.8%), and respiratory diseases (22.5%). Only 37% were vaccinated. The overall in-hospital mortality was 19%, including 9 vaccinated individuals. Elevated levels of CRP (mean: 90.44 mg/L in females, 115.98 mg/L in males), IL-6 (up to 1319 pg/mL), and D-dimers (up to 32.94 mg/L) were observed, correlating with disease severity. Ceftriaxone was the most used antibiotic (84% of patients), while dexamethasone and LMWH were standard treatments. Tocilizumab was used selectively in patients with IL-6 > 100 pg/mL. Older age, lack of vaccination, and comorbidities were major risk factors for severe COVID-19. High values of CRP, D-dimer, and IL-6 were consistent with a worse prognosis, aligning with international findings. Corticosteroids and anticoagulants were widely used and clinically justified, while the routine use of antibiotics such as ceftriaxone may not be supported by current evidence. These results underscore the importance of evidence-based treatment protocols and biomarker-guided risk stratification in managing hospitalized COVID-19 patients.
Zitieren
APA
Aebisher, D., Oleś, P., Czarnecka-Czapczyńska, M., Drobek, H., Bartusik-Aebisher, D., Dynarowicz, K., Mytych, W., Cieślar, G., & Kawczyk-Krupka, A. (2026). COVID-19: A Local Report on Patients in the Covid Ward in Bytom, Poland. Letters in Applied NanoBioScience, 15(2). https://doi.org/10.33263/lianbs152.076
Vancouver
Aebisher D, Oleś P, Czarnecka-Czapczyńska M, Drobek H, Bartusik-Aebisher D, Dynarowicz K, et al. COVID-19: A Local Report on Patients in the Covid Ward in Bytom, Poland. Letters in Applied NanoBioScience. 2026;15(2). doi:10.33263/lianbs152.076
BibTeX
@article{Aebisher2026,
author = {Aebisher, David and Oleś, Piotr and Czarnecka-Czapczyńska, Magdalena and Drobek, Hanna and Bartusik-Aebisher, Dorota and Dynarowicz, Klaudia and Mytych, Wiktoria and Cieślar, Grzegorz and Kawczyk-Krupka, Aleksandra},
title = {COVID-19: A Local Report on Patients in the Covid Ward in Bytom, Poland},
journal = {Letters in Applied NanoBioScience},
year = {2026},
volume = {15},
number = {2},
doi = {10.33263/lianbs152.076}
}
EUVIMED